Literature DB >> 6293268

Growth kinetics of Bp8 mouse ascites sarcoma after single dose whole body irradiation. I. Analysis of the relative and total numbers of cells in various parts of the cell cycle.

S Cao, S Skog, B Tribukait.   

Abstract

The effects of irradiation on the growth of the Bp8 mouse ascites sarcoma were analysed following doses of 1.75, 2.5, 5.0 and 8.0 Gy. From the total number of cells and the percentage of cells in G1, S-phase, G2 + M as measured by flow cytofluorometric DNA analysis and the mitotic index the total number of cells in the various parts of the cell cycle was estimated. After an initial delay in the increase in the cell numbers during the period of rapid growth the total number of cells shows a dose dependent decrease at the plateau stage of the ascites growth. This dose relationship is characterized by a shoulder type of curve with a D0 of about 6.5 Gy and Dq of about 2 Gy. This decrease in the total number of cells is caused by a decreasing number of G1, S-phase and mitotic cells while G2 cells generally remain at unchanged levels. This behaviour of the G2 cells reflects the preference of long-lasting blocking events in G2 of the cell cycle but may also indicate specific regulating processes linked to this type of cell. The ratio between the number of mitotic and G2 cells also decreases in a dose dependent way and is a sensitive indicator for irradiation effects even below the lowest dose (1.75 Gy) used in the present experiments.

Entities:  

Mesh:

Year:  1982        PMID: 6293268     DOI: 10.3109/02841868209134014

Source DB:  PubMed          Journal:  Acta Radiol Oncol        ISSN: 0349-652X


  2 in total

1.  A flow cytometric bromodeoxyuridine/DNA analysis for cytokinetics of the pancreatic cancer cell line Capan-2 after irradiation.

Authors:  B Nakata; Y S Chung; M Sowa
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

2.  Cytocidal and toxic effect of various cytostatic drugs on three ascites tumors of the mouse.

Authors:  E Schäfer; B Maurer-Schultze
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.